The DNA-damaging anti-cancer treatments (i.e. ionizing radiation and DNA-alkylating agent), inducing the accumulation of tumor-derived DNA, might be involved in the recruitment of activated pDCs to the TME, highlighting the TLR9 upregulation by pDCs in mice treated with cisplatin or ionizing radiation [208]. The gene discussed is TLR9; the disease is neoplasm.